The Hub has given us that destination. We now have somewhere we can point people to that genuinely reflects the company as it is today, not as it was six months ago when we last updated the corporate site.
Challenge
ValiRx is a clinical-stage life sciences company developing therapeutics for cancer and women's health, with an investor base that has very specific questions about pipeline progress. Like a lot of AIM biotech companies, its investor communication was fragmented: RNS went out, the website was updated periodically, and there were occasional investor events — but there was no single place where an investor could find everything, from the latest news and the pipeline to presentations and share price information.
Solution
The hub gives ValiRx that destination. Alongside formal announcements, the team publishes plain-English updates linked to each RNS, answers investor questions through public Q&A, and hosts results briefings and pipeline webinars — with recordings that stay on the hub afterwards.